Home › Funds › SALT Holding Corp. › GSK

SALT Holding Corp. position in GSK

GSK PLC · Health Care

SALT Holding Corp. reported holding 235,459 shares of GSK (GSK PLC) in its Q2 2026 13F filing — a position valued at US$12.3M, representing 6.54% of its reported portfolio and ranking #6 among its reported holdings. SALT Holding Corp. has disclosed GSK holdings in 3 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)235.46K sh
Reported value held$12.34M
Portfolio Weight6.54%
First reportedQ4 2024
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SALT Holding Corp.'s GSK position evolved

SALT Holding Corp. first disclosed a stake in GSK in Q4 2024 at 61,612 shares (US$2.1M). The position peaked in Q2 2026 at 235,459 shares, worth US$12.3M. Across 3 filings, SALT Holding Corp. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 235,459 shares valued at US$12.3M. Notable position changes include a 47% increase in Q1 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 61.61K $2.08M New
Q1 2025 90.66K $3.51M Add
Q2 2026 235.46K $12.34M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GSK and 13F data

GSK (GSK PLC) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has SALT Holding Corp. held GSK?

SALT Holding Corp. has disclosed GSK holdings in 3 of the last 7 reported quarters, going back to Q4 2024.

What is SALT Holding Corp.'s current position in GSK?

As of Q2 2026, SALT Holding Corp. holds 235.46K shares of GSK (GSK PLC), valued at $12.34M, representing 6.54% of its reported portfolio and ranking #6.

Has SALT Holding Corp. been buying or selling GSK?

In the latest 13F filing (Q2 2026), SALT Holding Corp. newly opened its position in GSK. The position peaked in Q2 2026 at 235.46K shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.